Literature DB >> 31553563

Mapping RNAPII CTD Phosphorylation Reveals That the Identity and Modification of Seventh Heptad Residues Direct Tyr1 Phosphorylation.

Nathaniel T Burkholder, Sarah N Sipe, Edwin E Escobar, Mukeshkumar Venkatramani, Seema Irani, Wanjie Yang, Haoyi Wu, Wendy M Matthews, Jennifer S Brodbelt, Yan Zhang.   

Abstract

The C-terminal domain (CTD) of the largest subunit in eukaryotic <span class="Gene">RNA polymerase II has a repetitive heptad sequence of Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7 which is responsible for recruiting transcriptional regulatory factors. The seventh heptad residues in mammals are less conserved and subject to various post-translational modifications, but the consequences of such variations are not well understood. In this study, we use ultraviolet photodissociation mass spectrometry, kinetic assays, and structural analyses to dissect how different residues or modifications at the seventh heptad position alter Tyr1 phosphorylation. We found that negatively charged residues in this position promote phosphorylation of adjacent Tyr1 sites, whereas positively charged residues discriminate against it. Modifications that alter the charges on seventh heptad residues such as arginine citrullination negate such distinctions. Such specificity can be explained by conserved, positively charged pockets near the active sites of ABL1 and its homologues. Our results reveal a novel mechanism for variations or modifications in the seventh heptad position directing subsequent phosphorylation of other CTD sites, which can contribute to the formation of various modification combinations that likely impact transcriptional regulation.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31553563      PMCID: PMC7025470          DOI: 10.1021/acschembio.9b00610

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  43 in total

1.  Tyrosine phosphorylation of RNA polymerase II carboxyl-terminal domain by the Abl-related gene product.

Authors:  R Baskaran; G G Chiang; T Mysliwiec; G D Kruh; J Y Wang
Journal:  J Biol Chem       Date:  1997-07-25       Impact factor: 5.157

2.  In vivo dynamics of RNA polymerase II transcription.

Authors:  Xavier Darzacq; Yaron Shav-Tal; Valeria de Turris; Yehuda Brody; Shailesh M Shenoy; Robert D Phair; Robert H Singer
Journal:  Nat Struct Mol Biol       Date:  2007-08-05       Impact factor: 15.369

3.  The CTD code.

Authors:  Stephen Buratowski
Journal:  Nat Struct Biol       Date:  2003-09

4.  MPK1/SLT2 Links Multiple Stress Responses with Gene Expression in Budding Yeast by Phosphorylating Tyr1 of the RNAP II CTD.

Authors:  Nathan Yurko; Xiaochuan Liu; Takashi Yamazaki; Mainul Hoque; Bin Tian; James L Manley
Journal:  Mol Cell       Date:  2017-12-07       Impact factor: 17.970

5.  Mechanism-based design of a protein kinase inhibitor.

Authors:  K Parang; J H Till; A J Ablooglu; R A Kohanski; S R Hubbard; P A Cole
Journal:  Nat Struct Biol       Date:  2001-01

6.  Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain.

Authors:  R Baskaran; M E Dahmus; J Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

7.  Cdc42-dependent nuclear translocation of non-receptor tyrosine kinase, ACK.

Authors:  Ijaz Ahmed; Yolanda Calle; Mohammed A Sayed; Jabeen M Kamal; Padmanabhan Rengaswamy; Ed Manser; Sally Meiners; Alam Nur-E-Kamal
Journal:  Biochem Biophys Res Commun       Date:  2004-02-06       Impact factor: 3.575

8.  Transcribing RNA polymerase II is phosphorylated at CTD residue serine-7.

Authors:  Rob D Chapman; Martin Heidemann; Thomas K Albert; Reinhard Mailhammer; Andrew Flatley; Michael Meisterernst; Elisabeth Kremmer; Dirk Eick
Journal:  Science       Date:  2007-12-14       Impact factor: 47.728

9.  RPRD1A and RPRD1B are human RNA polymerase II C-terminal domain scaffolds for Ser5 dephosphorylation.

Authors:  Zuyao Ni; Chao Xu; Xinghua Guo; Gerald O Hunter; Olga V Kuznetsova; Wolfram Tempel; Edyta Marcon; Guoqing Zhong; Hongbo Guo; Wei-Hung William Kuo; Joyce Li; Peter Young; Jonathan B Olsen; Cuihong Wan; Peter Loppnau; Majida El Bakkouri; Guillermo A Senisterra; Hao He; Haiming Huang; Sachdev S Sidhu; Andrew Emili; Shona Murphy; Amber L Mosley; Cheryl H Arrowsmith; Jinrong Min; Jack F Greenblatt
Journal:  Nat Struct Mol Biol       Date:  2014-07-06       Impact factor: 15.369

10.  Site-specific methylation and acetylation of lysine residues in the C-terminal domain (CTD) of RNA polymerase II.

Authors:  Kirsten Voss; Ignasi Forné; Nicolas Descostes; Corinna Hintermair; Roland Schüller; Muhammad Ahmad Maqbool; Martin Heidemann; Andrew Flatley; Axel Imhof; Marta Gut; Ivo Gut; Elisabeth Kremmer; Jean-Christophe Andrau; Dirk Eick
Journal:  Transcription       Date:  2015
View more
  4 in total

1.  Structural Motifs for CTD Kinase Specificity on RNA Polymerase II during Eukaryotic Transcription.

Authors:  Mukesh Kumar Venkat Ramani; Edwin E Escobar; Seema Irani; Joshua E Mayfield; Rosamaria Y Moreno; Jamie P Butalewicz; Victoria C Cotham; Haoyi Wu; Meena Tadros; Jennifer S Brodbelt; Yan Jessie Zhang
Journal:  ACS Chem Biol       Date:  2020-07-14       Impact factor: 5.100

Review 2.  What's all the phos about? Insights into the phosphorylation state of the RNA polymerase II C-terminal domain via mass spectrometry.

Authors:  Blase M LeBlanc; R Yvette Moreno; Edwin E Escobar; Mukesh Kumar Venkat Ramani; Jennifer S Brodbelt; Yan Zhang
Journal:  RSC Chem Biol       Date:  2021-06-03

3.  Evaluating Spatiotemporal Dynamics of Phosphorylation of RNA Polymerase II Carboxy-Terminal Domain by Ultraviolet Photodissociation Mass Spectrometry.

Authors:  Edwin E Escobar; Mukesh Kumar Venkat Ramani; Yan Zhang; Jennifer S Brodbelt
Journal:  J Am Chem Soc       Date:  2021-05-31       Impact factor: 16.383

Review 4.  Simplicity is the Ultimate Sophistication-Crosstalk of Post-translational Modifications on the RNA Polymerase II.

Authors:  Mukesh Kumar Venkat Ramani; Wanjie Yang; Seema Irani; Yan Zhang
Journal:  J Mol Biol       Date:  2021-03-05       Impact factor: 6.151

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.